Blood Cells Molecules and Diseases

Papers
(The median citation count of Blood Cells Molecules and Diseases is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Erythrocyte deformability correlates with systemic inflammation32
The utility of multiple genomic technologies for interpretation of modern next generation sequencing: A novel case of three FANCA gene variants resulting in autosomal recessive Fanconi anaemia32
Evidence for continued dose escalation of plerixafor for hematopoietic progenitor cell collections in sickle cell disease30
Rapid and automated quantitation of dense red blood cells: A robust biomarker of hydroxyurea treatment response25
The role of PKC in X-ray-induced megakaryocyte apoptosis and thrombocytopenia24
Differential effects of iron chelators on iron burden and long-term morbidity and mortality outcomes in a large cohort of transfusion-dependent β-thalassemia patients who remained on the same monother18
Investigation of the cytotoxicity, genotoxicity and antioxidant prospects of JM-20 on human blood cells: A multi-target compound with potential therapeutic applications16
Targeting of Calbindin 1 rescues erythropoiesis in a human model of Diamond Blackfan anemia16
Malignant histiocytosis with a Langerhans cell subtype: A report on the diagnostic and therapeutic challenge14
Commentary on “unmasking the morphological alteration of erythrocytes among women suffering from PCOS”14
Editorial Board12
Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP)11
Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?11
A computational study of structural differences of binding of NADP+ and G6P substrates to G6PD Mediterraneanc.563T, G6PD A−c.202A/c.376G, G6PD Cairoc.404C and G6PD Gazac.536A mutations11
Rare bleeding disorders: Real-world data from a Spanish tertiary hospital10
Editorial Board10
First report of a patient with homozygous hemoglobin Ernz: Evidence to support a non-pathogenic variant10
Characterization of peripheral T helper 17 (Th17) cells phenotype in postmenopausal women with estrogen insufficiency9
Editorial Board9
Mutations in RASGRP2 gene identified in patients misdiagnosed as Glanzmann thrombasthenia patients9
Megakaryocyte-specific knockout of the Mir-99b/let7e/125a cluster lowers platelet count without altering platelet function9
γ′ fibrinogen levels as a biomarker of COVID-19 respiratory disease severity9
Editorial Board9
Prognostic significance of CD45 antigen expression in pediatric acute lymphoblastic leukemia8
Artefactual decrease in the fluorescence intensity of hereditary spherocytosis EMA test related to statins8
Systemic corticosteroids in the treatment of warm autoimmune hemolytic anemia: A clinical setting perspective8
Cytogenetic profile and outcome of a pediatric acute promyelocytic leukemia patient presenting with isolated isochromosome 17q in absence of RARA rearrangement8
Drinking recommended daily water significantly alters haemato-biochemical parameters in prospective blood donors; a one-center quasi-experimental study in a tropical setting8
Editorial Board8
Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model7
Genetic examination of hematological parameters in SARS-CoV-2 infection and COVID-197
Up-regulation of microRNA 101-3p during erythropoiesis in β-thalassemia/HbE7
LXRβ is involved in the control of platelet production from megakaryocytes7
Outpatient ATG-free hematopoietic transplantation for aplastic anemia in limited-resource environments offers excellent results: Data from a single LATAM center7
The inhibitor of MyoD Family A (I-MFA) regulates megakaryocyte lineage commitment and terminal differentiation6
Daratumumab for pure red cell aplasia post ABO incompatible allogeneic hematopoietic stem cell transplant for aplastic anemia6
Indices of iron homeostasis in asymptomatic subjects with HFE mutations and moderate ferritin elevation during iron removal treatment6
Pancytopenia and thrombosis defects in zebrafish mutants of Fanconi anemia genes6
Acquired elliptocytosis in chronic myeloid neoplasms: An enigmatic relationship to acquired red cell membrane protein and genetic abnormalities6
Hypoferremia of inflammation: Innate host defense against infections5
Comprehensive analysis of sickle β+-thalassemia genotypes and their associated HbA levels in France5
Missense mutation in RPS7 causes Diamond-Blackfan anemia via alteration of erythrocyte metabolism, protein translation and induction of ribosomal stress5
Friend or foe? The case of Wilms' Tumor 1 (WT1) mutations in acute myeloid leukemia5
Manifestation of paroxysmal nocturnal hemoglobinuria after COVID-19 mRNA vaccination5
Daucosterol regulates JAK2-STAT3 signaling pathway to promote megakaryocyte differentiation5
Editorial Board5
Diamond-Blackfan anemia, the archetype of ribosomopathy: How distinct is it from the other constitutional ribosomopathies?5
Clinical and health-related quality of life outcomes of transfusion-dependent thalassaemia patients in Singapore5
Prognostic factors associated with COVID-19 related severity in sickle cell disease5
Extreme γ′ fibrinogen levels in COVID-19 patients5
Molecular characterization of a novel 83.9-kb deletion of the α-globin upstream regulatory elements by long-read sequencing5
PKLR mutations in pyruvate kinase deficient Polish patients: Functional characteristics of c.101-1G > A and c.1058delAAG variants4
Chronic lymphocytic leukemia with a transient atypical T-cell proliferation raising concern for T-cell lymphoma4
Mechanism of the apoptosis of bone marrow erythroblasts in rats under hypobaric hypoxia4
Retraction notice to “MZF1 regulates α-globin gene transcription via long-range interactions in erythroid differentiation” [Blood Cells, Mol. Dis., Volume 87, March 2021, 102533]3
Liver kinase B1 (LKB1) in murine erythroid progenitors modulates erythropoietin setpoint in association with maturation control3
Discovery of seven hox genes in zebrafish thrombopoiesis3
Corrigendum to “Impact of maternal iron deficiency anemia on fetal iron status and placental iron transporters in human pregnancy” [Blood Cells Mol. Dis. 99 (2023) 102727]3
Performance of serum procalcitonin as a biochemical predictor of death in hematology patients with febrile neutropenia3
Hematologically important mutations: Leukocyte adhesion deficiency (second update)3
Decreasing circ_0014614 promotes the differentiation of bone marrow flineage cells into megakaryocytes in essential thrombocythemia via activiation of miR-138-5p/caspase3 axis3
Early iron supplementation and iron sufficiency at one month of age in NICU patients at-risk for iron deficiency3
Isolated central nervous system relapse of acute promyelocytic leukemia with altered morphology in an asymptomatic patient3
Blood cells molecules and diseases in 2022: A fountain of youth3
Bio-net dataset: AI-based diagnostic solutions using peripheral blood smear images3
Bone marrow burden score is not useful as a follow-up parameter in stable patients with type 1 Gaucher disease after 5 years of treatment3
Editorial Board2
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort2
Analysis of baseline characteristics, disease burden and long-term follow-up of 167 patients with Paroxysmal Nocturnal Hemoglobinuria at a single center in Brazil2
Phenotypic and genotypic evaluation of bleeding diagnostic dilemmas: Two case studies2
Molecular and biochemical evaluation of oxidative effects of cord blood CD34+ MPs on hematopoietic cells2
Telomere shortening correlates with disease severity in hemoglobin H disease patients2
Rheumatological manifestations of chronic graft versus host disease - Case series2
Editorial Board2
Two new mutations in the GLRX5 gene cause sideroblastic anemia2
Thirty-five males with severe (Class 1) G6PD deficiency (c.637G>T) in a North American family of European ancestry2
Editorial Board2
Identification of Nfel1a and Nfel3 as novel regulators for zebrafish thrombopoiesis2
Immunodeficiency in children with Diamond Blackfan and Diamond Blackfan like anemia2
Further biological characterization of small molecules UM171 and SR1: In vitro effects on three hematopoietic cell populations from human cord blood2
Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-β thalassemia - a pilot study from a tertiary care Centre of India2
Mouse models of sickle cell disease: Imperfect and yet very informative2
The significance of surface neutrophilic MPO expression level in NETosis and NETosis-associated coagulopathies in covid-19 infected patients2
Editorial Board2
Corrigendum to “Clinical utility of relative telomere length analysis in pediatric bone marrow failure” [Blood Cells Mol. Dis. 109 (2024) 102882]2
Growth hormone is involved in GATA1 gene expression via STAT5B in human erythroleukemia and monocytic cell lines2
Impact of CD34 positive cell dose in donor graft on the outcomes after haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide – A retrospective single-center s2
Red cell anarchy. Evidence of neoplastic dyserythropoiesis2
Platelet activation and blood extracellular vesicles: The influence of venepuncture and short blood storage2
Co-morbidities and mortality in patients with sickle cell disease in England: A 10-year cohort analysis using hospital episodes statistics (HES) data2
Whole exome sequencing of a breast tumor in a patient with Diamond Blackfan anemia2
Anti-TFPI for hemostasis induction in patients with rare bleeding disorders, an ex vivo thrombin generation (TG) guided pilot study1
Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature1
Monoclonal IgM gammopathy in adult acquired pure red cell aplasia: culprit or innocent bystander?1
Regarding γ′ fibrinogen levels as a biomarker of COVID-19 respiratory disease severity1
Impact of maternal iron deficiency anemia on fetal iron status and placental iron transporters in human pregnancy1
Editorial Board1
Daratumumab as a novel treatment option in refractory ITP1
Surgical procedures and complications in placement of totally implantable venous access port in pediatric hemophilia patients: A retrospective analysis1
Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing1
Plasma immune mediators as laboratorial biomarkers for Sickle Cell Disease patients according to the hydroxyurea therapy and disease severity1
Reliability of different estimated glomerular filtration rate as measures of renal function in children with sickle cell disease1
Bach1 inhibitor HPP-D mediates γ-globin gene activation in sickle erythroid progenitors1
Good treatment-free survival of monoclonal gammopathy of undetermined significance associated pure red cell aplasia after bortezomib plus dexamethasone1
COVID-19 induces proatherogenic alterations in moderate to severe non-comorbid patients: A single-center observational study1
Effectiveness of convalescent plasma in Indian patients with COVID-191
Platelet counts on peripheral blood and Mean Platelet Volume as markers of clinical severity in Sickle Cell Disease1
Clonal hematopoiesis and acquired genetic abnormalities of the red cell: An historical review1
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort1
A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis1
Editorial Board1
Outcome of first or second transplantation using unrelated umbilical cord blood without ATG conditioning regimen for pediatric bone marrow failure disorders1
Effects of d-ribose on human erythrocytes: Non-enzymatic glycation of hemoglobin, eryptosis, oxidative stress and energy metabolism1
Clinical characteristics, laboratory features and genetic profile of hemoglobin E (HBB:c.79 G > A)/β (nucleotide -28 A > G) (HBB:c.-78 A > G) -thalassemia subjects identified from community- 1
0.12022304534912